<html>
<head>PUBMED IDs for CAMEL</head>
<body bgcolor='#C5F0F2'><h1>CAMEL</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10399963/'>Interleukin-2-induced, melanoma-specific T cells recognize CAMEL, an unexpected translation product of LAGE-1.</a> July 10  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/11120859/'>Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma.</a> December 20  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11948485/'>TCR reconstitution in Jurkat reporter cells facilitates the identification of novel tumor antigens by cDNA expression cloning.</a> April 12  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12538712/'>CD4+ Th2 cell recognition of HLA-DR-restricted epitopes derived from CAMEL: a tumor antigen translated in an alternative open reading frame.</a> January 23  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14726960/'>Induction of CAMEL/NY-ESO-ORF2-specific CD8+ T cells upon stimulation with dendritic cells infected with a modified Ad5 vector expressing a chimeric Ad5/35 fiber.</a> January 17  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15067093/'>Identification of multiple HLA-DR-restricted epitopes of the tumor-associated antigen CAMEL by CD4+ Th1/Th2 lymphocytes.</a> April 7  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/25801067/'>Combined Tumor Cell-Based Vaccination and Interleukin-12 Gene Therapy Polarizes the Tumor Microenvironment in Mice.</a> August 30  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/28638873/'>PROTECTIVE EFFECT OF CAMEL MILK AS ANTI-DIABETIC SUPPLEMENT: BIOCHEMICAL, MOLECULAR AND IMMUNOHISTOCHEMICAL STUDY.</a> June 24  2017<br></body></html>
